• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比例风险回归模型的样本量公式。

Sample-size formula for the proportional-hazards regression model.

作者信息

Schoenfeld D A

出版信息

Biometrics. 1983 Jun;39(2):499-503.

PMID:6354290
Abstract

A formula is derived for determining the number of observations necessary to test the equality of two survival distributions when concomitant information is incorporated. This formula should be useful in designing clinical trials with a heterogeneous patient population. Schoenfeld (1981, Biometrika 68, 316-319) derived the asymptotic power of a class of statistics used to test the equality of two survival distributions. That result is extended to the case where concomitant information is available for each individual and where the proportional-hazards model holds. The loss of efficiency caused by ignoring concomitant variables is also computed.

摘要

推导了一个公式,用于在纳入伴随信息时确定检验两个生存分布相等所需的观察次数。该公式在设计具有异质患者群体的临床试验中应会很有用。舍恩菲尔德(1981年,《生物统计学》68卷,316 - 319页)推导了用于检验两个生存分布相等的一类统计量的渐近功效。该结果被扩展到每个个体都有伴随信息且比例风险模型成立的情况。还计算了忽略伴随变量所导致的效率损失。

相似文献

1
Sample-size formula for the proportional-hazards regression model.比例风险回归模型的样本量公式。
Biometrics. 1983 Jun;39(2):499-503.
2
Comparison of procedures for testing the equality of survival distributions.生存分布相等性检验程序的比较。
Biometrics. 1981 Jun;37(2):327-40.
3
The problem of a covariate-time qualitative interaction in a survival study.生存研究中协变量-时间定性交互作用的问题。
Biometrics. 1991 Mar;47(1):101-15.
4
[Meta-analysis of the Italian studies on short-term effects of air pollution].[意大利关于空气污染短期影响研究的荟萃分析]
Epidemiol Prev. 2001 Mar-Apr;25(2 Suppl):1-71.
5
Sample size and duration for cohort studies of survival time with covariables.带有协变量的生存时间队列研究的样本量和持续时间。
Biometrics. 1983 Jun;39(2):351-60.
6
Goodness of fit methods for the proportional hazards regression model: a review.比例风险回归模型的拟合优度方法:综述
Rev Epidemiol Sante Publique. 1984;32(3-4):185-98.
7
Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.长期暴露于交通相关空气污染对荷兰呼吸道和心血管疾病死亡率的影响:荷兰长期队列空气污染研究(NLCS-AIR研究)
Res Rep Health Eff Inst. 2009 Mar(139):5-71; discussion 73-89.
8
Properties of proportional-hazards score tests under misspecified regression models.错误设定回归模型下比例风险评分检验的性质。
Biometrics. 1984 Dec;40(4):1037-48.
9
Evaluation of sample size and power for analyses of survival with allowance for nonuniform patient entry, losses to follow-up, noncompliance, and stratification.在考虑患者入组不均匀、失访、不依从和分层的情况下,对生存分析的样本量和检验效能进行评估。
Biometrics. 1986 Sep;42(3):507-19.
10
A regression survival model for testing the proportional hazards hypothesis.用于检验比例风险假设的回归生存模型。
Biometrics. 1996 Sep;52(3):874-85.

引用本文的文献

1
Association Between the Frailty Index Based on Laboratory Tests and All-Cause Mortality in Hospitalized Older Adults: Retrospective Cohort Study.基于实验室检查的衰弱指数与住院老年人全因死亡率之间的关联:回顾性队列研究
JMIR Aging. 2025 Sep 10;8:e70204. doi: 10.2196/70204.
2
Design aspects for prognostic factor studies.预后因素研究的设计方面。
BMJ Open. 2025 Aug 31;15(8):e095065. doi: 10.1136/bmjopen-2024-095065.
3
Toripalimab Combination Therapy Without Concurrent Cisplatin for Nasopharyngeal Carcinoma: The DIAMOND Randomized Clinical Trial.
特瑞普利单抗联合疗法治疗鼻咽癌时不联合顺铂:DIAMOND随机临床试验
JAMA. 2025 Aug 21. doi: 10.1001/jama.2025.13205.
4
Program for Psychosocial Assessment During Pregnancy: Protocol for a Multimethod Study.孕期心理社会评估项目:多方法研究方案
JMIR Res Protoc. 2025 Aug 1;14:e67179. doi: 10.2196/67179.
5
Feasibility of Hypotension Prediction Index-Guided Monitoring for Epidural Labor Analgesia: A Randomized Controlled Trial.低血压预测指数指导下的硬膜外分娩镇痛监测的可行性:一项随机对照试验
J Clin Med. 2025 Jul 16;14(14):5037. doi: 10.3390/jcm14145037.
6
Joint modeling of predictors of adverse drug reactions and viral load changes over time among adult patients on ART at Nigist Eleni Mohammed Memorial comprehensive specialized hospital, central Ethiopia.埃塞俄比亚中部尼吉斯特·埃莱尼·穆罕默德纪念综合专科医院接受抗逆转录病毒治疗的成年患者中药物不良反应预测因素与病毒载量随时间变化的联合建模。
BMC Infect Dis. 2025 Jul 12;25(1):915. doi: 10.1186/s12879-025-11294-7.
7
Toxicity of ivermectin to bed bugs (Cimex hemipterus) and risk factors associated with infestation in Kwale County, coastal Kenya.伊维菌素对臭虫(热带臭虫)的毒性以及肯尼亚沿海夸莱县臭虫侵扰的相关风险因素
Parasit Vectors. 2025 Jul 8;18(1):269. doi: 10.1186/s13071-025-06836-6.
8
Osimertinib plus chemotherapy versus osimertinib for patients with advanced NSCLC with concomitant EGFR and TP53 mutations: a prospective cohort study.奥希替尼联合化疗与奥希替尼治疗伴有EGFR和TP53突变的晚期非小细胞肺癌患者的前瞻性队列研究
Sci Rep. 2025 Jul 1;15(1):20952. doi: 10.1038/s41598-025-03422-9.
9
Predictors of PASI90 response in patients with psoriasis treated with ınterleukin ınhibitors: observational cohort study.接受白细胞介素抑制剂治疗的银屑病患者达到PASI90缓解的预测因素:观察性队列研究。
An Bras Dermatol. 2025 Jun 18;100(4):501132. doi: 10.1016/j.abd.2025.501132.
10
Comparison of the prognostic value of complete blood count-derived inflammatory markers for long-term outcomes in ST-segment elevation myocardial infarction.全血细胞计数衍生的炎症标志物对ST段抬高型心肌梗死长期预后价值的比较
Intern Emerg Med. 2025 Jun 16. doi: 10.1007/s11739-025-04018-x.